F. Hoffmann-La Roche Ltd (release of finished medicinal product; quality control testing upon release and stability (excluding microbiological purity), primary and secondary packaging, including in-process control, release of finished medicinal product; quality control testing upon release and stability (only microbiological purity))

The drug is used for the treatment of influenza in patients aged 12 years and older, as well as for the prevention of influenza after close contact with an infected person.

Dosage form: tablets, film-coated

ATC: J05AX25